Point Out Statins' CV Benefits STILL Outweigh Diabetes Risk

September 2014

You'll hear more about higher doses of statins increasing diabetes risk...partly due to reports of lawsuits in the lay press.

Help put this into perspective for patients.

Explain that statins' CV benefits STILL outweigh diabetes risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote